The Samsung Galaxy S3 is 10 years old now: A tale of a different time

samsung galaxy s3 high res 3

The year is 2012. Nokia is still on top of the smartphone world, but Apple is knocking on its door. Ice Cream Sandwich and its Holo design aesthetic have been making their (slow) way to some Android phones. The Android Market has just been rebranded to Google Play. 720p displays are hot, quad-core processors are at the bleeding edge, and a phone with a 5.3″ display is considered a “phablet.”

The year is 2012 and Samsung is rising like a rocket in the mobile market by perfecting a strategy it established two years prior with the first Galaxy S phone. It’s building a flagship line that competes with Apple, runs Google’s platform and application store, offers the best specifications, and is available in as many countries and on as many carriers as possible like Nokia once was. After the decent success of the Galaxy S and the incredible rise of the Galaxy S2 which firmly established Samsung as a worldwide contender and not a one-hit-wonder, the Galaxy S3 had big shoes to fill when it launched on May 29, 2012. Ten whole years ago.



from Android Authority https://ift.tt/59az6tV
via IFTTT

Comments

Post a Comment

Popular posts from this blog

6 investors discuss why AI is more than just a buzzword in biotech

As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. “Most of the companies we have seen have an AI component to support the discovery or development processes,” Francisco Dopazo, a general partner at Humboldt Fund told TechCrunch recently. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations. So to get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today. For Franck Lescure, a partner at Elaia Partners, in biotech, having an AI component isn’t an automatic deal closer. “We do not favor biotech startups with extant AI over those without: Bio-revolution is not only digital. Digital is one tool; the other major tool is the livin
Read more

Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures (Igor Bosilkovski/Forbes)

Image
Igor Bosilkovski / Forbes : Voiceflow, a Canada-based SaaS platform that lets companies launch their own voice and chat bots, raises $20M Series A led by Felicis Ventures   —  Canadian collaborative conversational AI tool Voiceflow announced today that it has raised $20 million in a Series A round led by Felicis Ventures. from Techmeme https://ift.tt/3rFQ9St via IFTTT
Read more

Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics (Adam Rawnsley/Rolling Stone)

Image
Adam Rawnsley / Rolling Stone : Ex-staffers say Twitter's mass firing of security staff and growing reliance on automation will help China and other authoritarian regimes in silencing critics   —  Elon's mass firing of security staff and increased reliance on automation is going to make it easier for tyrants to shout … from Techmeme https://ift.tt/xQsF2ef via IFTTT
Read more